Effect on Exercise Endurance and Lung Hyperinflation of Tiotropium + Olodaterol in COPD Patients

NCT01533922 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

295

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: Placebo
DRUG: Tiotropium
DRUG: Olodaterol
DRUG: tiotropium + olodaterol
DRUG: Tiotropium + Olodaterol
DEVICE: Respimat

Sponsor

Boehringer Ingelheim